Autoimmune liver diseases (AILDs), including autoimmune hepatitis, primary biliary cholangitis, primary sclerosing ...
We read with interest the Rome Foundation paediatric global study by Nurko and colleagues,1 which establishes a multinational ...
Background Advances in systemic therapy for advanced hepatocellular carcinoma (HCC) have fuelled a growing interest in ...
Background The impact of circulating tumour DNA (ctDNA) detection, which informs minimal residual disease (MRD) after ...
Background Hospitalisations represent major clinical events in cirrhosis, yet prediction based on clinical variables alone ...
Metastatic pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest solid cancers, portending poor patient outcomes ...
Background Patients with gastric cancer (GC) and peritoneal metastasis (PM) have poor prognoses due to drug resistance and metastatic relapse. The mechanism underlying PM recurrence remains unclear.
1 Translational and Clinical Research Institute and NIHR Newcastle Biomedical Research Center, Newcastle University, Newcastle Upon Tyne, UK, Newcastle Upon Tyne, UK 2 Division of Gastroenterology and ...
Objective SETD2, the sole histone H3K36 trimethyltransferase, is frequently mutated or deleted in human cancer, including pancreatic ductal adenocarcinoma (PDAC). However, whether SETD2/H3K36me3 ...
3 Department of Internal Medicine, Ullevål University Hospital, Oslo, Norway 4 Department of Internal Medicine, Diakonhjemmet Hospital, Oslo, Norway 5 Department of Internal Medicine, Telemark ...
Bacterial infection is a frequent trigger of acute-on-chronic liver failure (ACLF), syndrome that could also increase the risk of infection. This investigation evaluated prevalence and characteristics ...